Submental Flap for the Reconstruction of Hypopharyngectomy
SMFRLPD
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this observational study is to assess the safety and efficacy of submental artery island flap (SMAIF) in the reconstruction of laryngeal and hypopharyngal defects after the surgical resection of hypopharyngeal cancer. The main questions it aims to answer are:
- The survival of SMAIF and the recovery of laryngeal function.
- The oncologic outcomes of SMAIF comparing with other reconstructions or radiotherapy. Participants will underwent partial laryngectomy and hypopharyngectomy and reconstruction of SMAIF. Postoperative adjuvant radiotherapy will be recommented when adverse pathologic features were noted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 16, 2023
CompletedFirst Submitted
Initial submission to the registry
September 4, 2023
CompletedFirst Posted
Study publicly available on registry
December 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 16, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 16, 2030
December 8, 2023
December 1, 2023
5 years
September 4, 2023
December 7, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
The survival of submental artery island flap
The survival rate of submental artery island flap (SMAIF)
one month after the end of the treatment
The recovery of laryngeal function
the removal of nasogastric tube and tracheal tube
one month after the end of the treatment
Secondary Outcomes (3)
Overall survival of patients underwent the treatment with SMAIF reconstruction.
2-year and 5-year after the initiation of treatment
Disease-free survival of patients underwent the treatment with SMAIF reconstruction.
2-year and 5-year after the initiation of treatment
Local control rate of patients underwent the treatment with SMAIF reconstruction.
2-year and 5-year after the initiation of treatment
Study Arms (1)
Submental artery flap reconstruction group
EXPERIMENTALInterventions
submental artery island flap (SMAIF) for the reconstruction of laryngeal and hypopharyngal defects after the surgical resection of hypopharyngeal cancer
Eligibility Criteria
You may qualify if:
- T2-T3 hypopharyngeal squamous cell carcinoma located in the piriform sinus or posterior hypopharyngeal wall cancer;
- The contralateral hemilarynx is mobile;
- the Eastern Cooperative Oncology Group (ECOG) performance status (PS) score was 0 or 1;
- Without a history of radiotherapy.
You may not qualify if:
- Invasion into the cricoid cartilage and unable to reserve the larynx;
- Pulmonary insufficiency, FEV1/FVC\<50%;
- Unresctable neck diseases including carotid artery envoloped or tumor penetration to the prevertebral fascia or mediastinum;
- Heart insufficincy whice intolerate to general anesthesia;
- With distant metastasis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
Related Publications (10)
Jang JY, Kim EH, Cho J, Jung JH, Oh D, Ahn YC, Son YI, Jeong HS. Comparison of Oncological and Functional Outcomes between Initial Surgical versus Non-Surgical Treatments for Hypopharyngeal Cancer. Ann Surg Oncol. 2016 Jun;23(6):2054-61. doi: 10.1245/s10434-016-5088-4. Epub 2016 Jan 19.
PMID: 26786092BACKGROUNDMartin D, Pascal JF, Baudet J, Mondie JM, Farhat JB, Athoum A, Le Gaillard P, Peri G. The submental island flap: a new donor site. Anatomy and clinical applications as a free or pedicled flap. Plast Reconstr Surg. 1993 Oct;92(5):867-73.
PMID: 8415968BACKGROUNDChen R, Cai Q, Lin P, Liang F, Han P, Zhang L, Song P, Zhang T, Huang X. Role of immune-inflamed phenotype in the prognosis of hypopharyngeal carcinoma following primary surgery. Head Neck. 2023 Jan;45(1):126-134. doi: 10.1002/hed.27218. Epub 2022 Oct 12.
PMID: 36222335BACKGROUNDSung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
PMID: 33538338RESULTGarneau JC, Bakst RL, Miles BA. Hypopharyngeal cancer: A state of the art review. Oral Oncol. 2018 Nov;86:244-250. doi: 10.1016/j.oraloncology.2018.09.025. Epub 2018 Oct 4.
PMID: 30409307RESULTHabib A. Management of advanced hypopharyngeal carcinoma: systematic review of survival following surgical and non-surgical treatments. J Laryngol Otol. 2018 May;132(5):385-400. doi: 10.1017/S0022215118000555.
PMID: 29891019RESULTEckel HE, Bradley PJ. Treatment Options for Hypopharyngeal Cancer. Adv Otorhinolaryngol. 2019;83:47-53. doi: 10.1159/000492308. Epub 2019 Feb 12.
PMID: 30943512RESULTCai Q, Liang F, Huang X, Han P, Pan Y, Zheng Y. Hypopharynx and larynx defect repair after resection for pyriform fossa cancer with a platysma skin flap. Otolaryngol Head Neck Surg. 2015 Feb;152(2):374-6. doi: 10.1177/0194599814559508. Epub 2014 Nov 26.
PMID: 25428776RESULTChen L, Si Y, Lin P, Guan Z, Zhu W, Liang H, Cai Q. Surgical treatment of T2-3 posterior hypopharyngeal carcinoma with preservation of laryngeal function. Acta Otolaryngol. 2021 Sep;141(9):851-856. doi: 10.1080/00016489.2021.1965211. Epub 2021 Aug 30.
PMID: 34459710RESULTPang W, Zhang A, Lu C, Tian J, Li WX, Wang Z, Dong Y, Yuan S, Niu Z, Zhu Y, Quraishi MS, Liu L. Design and application of submental island flap to reconstruct non-circumferential defect after hypopharyngeal carcinoma resection: a prospective study of 27 cases. Acta Otolaryngol. 2020 Dec;140(12):1036-1042. doi: 10.1080/00016489.2020.1804614. Epub 2020 Aug 18.
PMID: 32808843RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaoming Huang, MD
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2023
First Posted
December 8, 2023
Study Start
February 16, 2023
Primary Completion (Estimated)
February 16, 2028
Study Completion (Estimated)
February 16, 2030
Last Updated
December 8, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share